Back to top

$IBRX stock is down 9% today. Here's what we see in our data.

$IBRX stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $44,052,908 of trading volume.

It has been the 181st most-searched ticker on Quiver Quantitative over the last day, out of 13,089 total tickers searched.

Here is what we see in our data on $IBRX (you can track the company live on Quiver's $IBRX stock page):

$IBRX Insider Trading Activity

IBRX Insider Trades

$IBRX insiders have traded $IBRX stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $IBRX stock by insiders over the last 6 months:

  • BARRY J. SIMON has made 0 purchases and 7 sales selling 450,000 shares for an estimated $4,140,898.
  • CHRISTOBEL SELECKY has made 0 purchases and 5 sales selling 196,722 shares for an estimated $1,558,865.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$IBRX Hedge Fund Activity

We have seen 247 institutional investors add shares of $IBRX stock to their portfolio, and 78 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive IBRX Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$IBRX Analyst Ratings

Wall Street analysts have issued reports on $IBRX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 05/21/2026
  • HC Wainwright & Co. issued a "Buy" rating on 02/23/2026
  • Piper Sandler issued a "Overweight" rating on 01/20/2026
  • D. Boral Capital issued a "Buy" rating on 01/20/2026

To track analyst ratings and price targets for $IBRX, check out Quiver Quantitative's $IBRX forecast page.

$IBRX Price Targets

Multiple analysts have issued price targets for $IBRX recently. We have seen 6 analysts offer price targets for $IBRX in the last 6 months, with a median target of $12.0.

Here are some recent targets:

  • Andres Y. Maldonado from HC Wainwright & Co. set a target price of $15.0 on 06/02/2026
  • Jeet Mukherjee from BTIG set a target price of $12.0 on 05/21/2026
  • Jason Kolbert from D. Boral Capital set a target price of $23.0 on 05/05/2026
  • Edward Tenthoff from Piper Sandler set a target price of $12.0 on 03/04/2026

You can track data on $IBRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ImmunityBio, Inc. (IBRX)